千珍品牌怎么样 申请店铺

我要投票 千珍在医疗器械行业中的票数:636 更新时间:2026-02-13
千珍是哪个国家的品牌?「千珍」是 广西千珍制药有限公司 旗下著名品牌。该品牌发源于广西南宁市,由创始人余平德在2004-06-18期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力千珍品牌出海!将品牌入驻外推网,定制千珍品牌推广信息,可以显著提高千珍产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

千珍怎么样

千珍(长安)制药是一个集天然药物研发、中药提取、生产、营销于一体的综合性现代化制药企业,公司总部位于国家第四个经济区北部湾核心城市南宁,目前拥有千珍制药(位于南宁)、长安制药(位于柳州融安县)两个具规模的中药现代化生产基地,其药品生产有40年历史,厂区按GMP标准设计建造,以绿色生态环境生产为标准,已建成中药提取、颗粒剂、片剂、胶囊剂、口服液、糖浆剂、酊剂、煎膏剂等生产基地。

千珍牌系列产品以治疗百姓家庭常见病为主体,拥有感冒止咳类、儿童类以及综合类等系列产品。系列产品分布感冒止咳良药的感冒止咳糖浆、止咳枇杷糖浆、川贝枇杷糖浆、二冬膏、板蓝根颗粒(无糖型)、蛇胆川贝液等产品;儿童专用药的山楂麦曲颗粒儿童装、小儿复方麻黄碱桔梗糖浆、大山楂颗粒儿童装、小儿化痰止咳颗粒等治疗儿童常见的消化不良、感冒咳嗽等症状;综合类产品拥有复方罗汉果止咳片、参芪首乌补汁、罗汉果玉竹颗粒、维C银翘片(薄膜衣片)、牛黄上清片、消炎利胆片、消炎片(薄膜衣片)等家庭日常用药。

千珍(长安)制药高度注重研发创新,公司在南宁设有产品研发中心,并与中国科学院上海药物研究所、韩国Chemizon药业技术公司等国内外专业药物研究机构结成的战略合作伙伴追随国家对中医民族药的开发与重视,千珍(长安)制药2009年整合资源以新形象面市,公司董事会决策推出“千珍品牌运作工程”——决心做老百姓心中的品牌药,对产品生产技术、产品用料、产品包装进行提升。


Qianzhen (Chang'an) Pharmaceutical Co., Ltd. is a comprehensive modern pharmaceutical enterprise integrating natural drug research and development, Chinese medicine extraction, production and marketing. Its headquarter is located in Nanning, the core city of Beibu Gulf, the fourth economic zone of China. At present, it has two large-scale modern production bases of Chinese medicine, qianzhen (Nanning) and Chang'an (Rongan County, Liuzhou) It has a history of 40 years. The factory is designed and built according to GMP standard, taking the production of green ecological environment as the standard, and has established the production bases of traditional Chinese medicine extraction, granules, tablets, capsules, oral liquids, syrups, tinctures, decoctions, etc. Qianzhen brand series products take the treatment of common diseases of common people's families as the main body, with cold and cough relief, children's and comprehensive series products. The series of products are mainly distributed in cold cough syrup, cough loquat syrup, Chuanbei loquat syrup, Erdong cream, Banlangen Granules (sugar free type), Hedan Chuanbei liquid and other products; children's special medicines such as hawthorn maiqu granules children's clothing, children's Compound Ephedrine and Platycodon syrup, big Hawthorn granules children's clothing, children's Huatan Zhike granules and other products to treat children's common dyspepsia Symptoms such as cold and cough; comprehensive products include compound Luohanguo cough tablet, shenqishouwu Buzhi, Luohanguo Yuzhu granules, vitamin C Yinqiao tablet (film coated tablet), Niuhuang Shangqing tablet, Xiaoyan Lidan tablet, Xiaoyan tablet (film coated tablet) and other household daily drugs. Qianzhen (Chang'an) pharmaceutical attaches great importance to R & D and innovation. The company has a product R & D center in Nanning, and strategic partners with Shanghai Pharmaceutical Research Institute of Chinese Academy of Sciences, Chemizon pharmaceutical technology company of South Korea and other professional pharmaceutical research institutions at home and abroad follow the country's development and attention to traditional Chinese medicine. In 2009, qianzhen (Chang'an) pharmaceutical integrated resources and launched a new image, The board of directors of the company decided to launch the "qianzhen brand operation project" - determined to be the brand medicine in the hearts of the common people, and improve the production technology, product materials and product packaging.

本文链接: https://brand.waitui.com/9fc58e1a7.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

热门中概股美股盘前多数下跌,理想汽车跌超1%

36氪获悉,热门中概股美股盘前多数下跌,截至发稿,京东、B站、腾讯音乐、理想汽车跌超1%,百度跌0.94%,蔚来跌0.79%,小鹏汽车跌0.77%,阿里巴巴跌0.74%,爱奇艺跌0.52%;网易涨近1%。

2小时前

翔鹭钨业:如钨精矿价格剧烈变化而钨制品价格未能同步变动,将对公司经营业绩产生影响

36氪获悉,翔鹭钨业公告,公司生产所需的钨精矿基本通过外购获得,公司产品的销售价格根据钨精矿价格变动情况相应调整,从而降低了原材料价格波动对公司经营业绩的影响,但如果未来钨精矿价格发生剧烈变化而钨制品价格未能同步变动,将会对公司主要产品的毛利率水平及经营业绩产生影响。

2小时前

中芯国际:存储器、BCD供不应求都在涨价

36氪获悉,中芯国际公告,在11月份业绩说明会上,有提到存储大周期对于产业和晶圆代工业的影响。在这样的市场环境下,公司凭借在BCD、模拟、存储、MCU、中高端显示驱动等细分领域中的技术储备与领先优势、客户的产品布局,在本轮行业发展周期中,仍能保持有利位置。公司将积极响应市场的紧急需求,推动2026年收入继续增长。价钱是一种供需的关系。中芯国际的存储器、BCD供不应求,都是在涨价的,友商部分成熟的产能不做了,市场上的供应量是在下降的。

2小时前

沪电股份:拟投资33亿元新建高端印制电路板生产项目

36氪获悉,沪电股份公告,公司于2026年2月11日召开的第八届董事会第十四次会议审议通过《关于新建高端印制电路板生产项目的议案》,同意投资新建“高端印制电路板生产项目”,生产高层数、高频高速、高密度互连、高通流PCB,以满足高速运算服务器、下一代高速网络交换机等对高端印制电路板的中长期增量需求。本项目总投资约为33亿元人民币,建成后预计年新增产能14万平方米高端印制电路板的生产规模,预计年新增营业收入30.5亿元人民币。

2小时前

引航生物递表港交所

36氪获悉,据港交所,苏州引航生物科技股份有限公司向港交所提交上市申请书,独家保荐人为华泰国际。

2小时前

本页详细列出关于千珍的品牌信息,含品牌所属公司介绍,千珍所处行业的品牌地位及优势。
咨询